Cargando…
Trends and advances in tumor immunology and lung cancer immunotherapy
Among several types of tumor, lung cancer is considered one of the most fatal and still the main cause of cancer-related deaths. Although chemotherapeutic agents can improve survival and quality of life compared with symptomatic treatment, cancers usually still progress after chemotherapy and are of...
Autores principales: | Aldarouish, Mohanad, Wang, Cailian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043622/ https://www.ncbi.nlm.nih.gov/pubmed/27686848 http://dx.doi.org/10.1186/s13046-016-0439-3 |
Ejemplares similares
-
Immunomodulatory effects of chemotherapy on blood lymphocytes and survival of patients with advanced non-small cell lung cancer
por: Aldarouish, Mohanad, et al.
Publicado: (2019) -
Primer on tumor immunology and cancer immunotherapy
por: Harris, Timothy J, et al.
Publicado: (2013) -
Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers
por: Li, Bo, et al.
Publicado: (2023) -
Ubiquitinated proteins enriched from tumor cells by a ubiquitin binding protein Vx3(A7) as a potent cancer vaccine
por: Aldarouish, Mohanad, et al.
Publicado: (2015) -
Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
por: Błach, Justyna, et al.
Publicado: (2021)